Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis
Introduction
Non-alcoholic steatohepatitis (NASH) is a frequent syndrome that has only recently become widely recognized as a source of liver injury. The prevalence of NASH is known to be rising worldwide, particularly in the United States, where NASH is now the most frequent liver disorder seen in primary care and in liver referral centers [1]. Because of its increasing importance, considerable efforts are being made to study NASH and elucidate the pathophysiologic mechanisms behind the disease. One model under discussion is the ‘two-hit’ hypothesis [2]. In this model, the normal liver becomes steatosis after prolonged central obesity. This ‘first hit’ then sensitizes the liver to further damage from several different mechanisms currently under study. Examples of these mechanisms include oxidative stress, insulin resistance, excessive tumor necrosis factor-α, antitoxin, and adenosine 5′-triphosphate (ATP) depletion. These ‘second hits’ then lead to the hepatitis seen in NASH and to subsequent fibrosis [3].
Genetic variation in lipid metabolism may produce differences in the speed and extent of hepatocyte lipid accumulation, the first hit. One enzyme that has attracted some interest is the microsomal triglyceride transfer protein (MTP). This protein transfers triglycerides to nascent apolipoprotein B, producing very low-density lipoprotein (VLDL) and removing lipid from the hepatocyte. Murine models have shown that the steatosis observed in hepatitis C infection results from inhibition of MTP by the hepatitis C viral core protein [4]. Patients with abetalipoproteinemia, an autosomal recessive disease caused by mutations in the MTP coding region, develop marked hepatic steatosis early in life [5], [6]. MTP mRNA is down regulated in human hepatocytes by insulin [7]. A common polymorphism in the MTP gene promoter, −493 G/T, has been described, with the G allele producing less gene transcription than the T allele [8], [9].
There is considerable evidence for the role of oxidative damage in NASH, one of the second hits. Lipid peroxidation likely damages plasma and intracellular membranes, leading to apoptosis and necrosis of hepatocytes. Lipid peroxidation end products (malondialdehyde and 4-hydroxy-2-nonenal (HNE)) may also trigger inflammatory and immune-mediated mechanisms of hepatocyte injury [3]. Animal models of non-alcoholic fatty liver disease [10] and biopsies of human patients with alcoholic liver disease [11] have shown that the degree of lipid peroxidation in the liver correlates with the extent of steatosis. It is suspected that free fatty acids may generate increased amounts of reactive oxygen species (ROS) by three different mechanisms. In a steatotic liver, free fatty acids are diverted to the mitochondria, where they are oxidized by beta-oxidation [3].
One enzyme that is important in detoxifying mitochondrial ROS is manganese superoxide dismutase (MnSOD). This enzyme is synthesized in the cytosol, then post-transcriptionally modified for transport to the mitochondria [12]. A limited number of polymorphisms have been described for MnSOD, including a T/C polymorphism in the mitochondrial targeting sequence. This polymorphism leads to a valine-to-alanine amino acid change in the mitochondrial targeting sequence [13]. In turn, this amino acid substitution may alter the helical structure of the mitochondrial targeting sequence, enhancing transport of MnSOD into the mitochondrial matrix [14].
We hypothesized that both MTP and MnSOD have an important role in determining an individual's susceptibility to NASH. The aim of our study was to examine the frequency of the MTP gene G/T polymorphism, and the MnSOD gene T/C polymorphism in Japanese NASH patients, and to compare these frequencies to those of healthy controls.
Section snippets
Patients and healthy controls
Liver biopsies had been obtained in patients with non-alcoholic fatty liver disease after thorough clinical evaluation and signed informed consent by each patient. Liver biopsy was analyzed by a pathologist (H.E.) and the diagnosis of NASH is based on Brunt's criteria [15], [16]. Patients with known use of methotrexate, tamoxifen, corticoids, insulin or alcohol in excess of 20 g per day and patients with other known causes of liver disease including viral hepatitis, hemochromatosis, Wilson
Ballooned hepatocytes and HNE deposition in hepatocytes
Ballooned hepatocytes and severe hepatic steatosis are characteristic pathological features observed in NASH (Fig. 1). Excessive fat deposition in the liver may result in enhanced fatty acid beta-oxidation since HNE, a marker of excessive oxidative stress, is deposited in the liver of 9 of 15 NASH patients independent of the degree of steatosis, inflammation and fibrosis (Fig. 2a). Spotty deposition of HNE in hepatocytes suggests preferential deposition in mitochondria. These results were
Discussion
Our results show that the G allele of the MTP gene promoter is more prevalent in NASH patients than in healthy volunteers. In agreement with this observation, CT revealed that the liver/spleen ratio was significantly lower in the G/G-genotype group than that in the G/T-genotype group (Table 2): i.e., the degree of hepatic steatosis in NASH patients with the G/G-genotype was significantly severer than that in NASH patients with the G/T-genotype [21]. This observation was confirmed in liver
References (32)
- et al.
Microsomal triglyceride transfer protein
Biochim Biophys Acta
(1997) - et al.
Liver ultrastructure in abetalipoproteinemia: evolution of micronodular cirrhosis
Gastroenterology
(1974) - et al.
Acute and chronic steatosis lead to in vivo lipid peroxidation in mice
J Hepatol
(1996) - et al.
Synthesis and processing of the precursor for human mangano-superoxide dismutase
Biochim Biophys Acta
(1989) - et al.
Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis
Hepatology
(2002) - et al.
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
Am J Gastroenterol
(1999) - et al.
Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease
Biochem Biophys Res Commun
(1996) - et al.
Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese
Biochem Biophys Res Commun
(1999) - et al.
The utility of radiological imaging in nonalcoholic fatty liver disease
Gastroenterology.
(2002) - et al.
Steatosis in chronic hepatitis C: relative contribution of obesity, diabetes mellitus, and alcohol
Hepatology
(2002)
Tamoxifen-associated steatohepatitis—report of three cases
J Hepatol
Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?
J Gastroenterol Hepatol
Steatohepatitis: a tale of two ‘hits’?
Gastroenterology
Non-alcoholic steatohepatitis: definitions and pathogenesis
J Gastroenterol Hepatol
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis
Fed Am Soc Exp Biol J
Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells. Roles of MAPK/erk and MAPK/p38
Diabetes
Cited by (221)
Post-Liver Transplant Metabolic Syndrome
2024, Journal of Clinical and Experimental HepatologyBerberine prevents NAFLD and HCC by modulating metabolic disorders
2024, Pharmacology and TherapeuticsGenetic Markers Predisposing to Nonalcoholic Steatohepatitis
2023, Clinics in Liver DiseaseNAFLD: genetics and its clinical implications
2022, Clinics and Research in Hepatology and GastroenterologyCitation Excerpt :An antioxidant enzyme manganese superoxide dismutase (SOD2) is enciphered by the SOD2 gene. It has been reported that the T allele is associated with higher enzyme activity in the rs4880 C47T polymorphism in the SOD2 gene, which causes valine to alanine amino acid substitutions in the signal region [50] Henceforth, qualitative and quantitative lipid content alteration in hepatocyte results in fatty liver development and progression. These studies highlight the necessary finding for complementary approaches to study pathophysiology of FLD.
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment
2022, Cytokine and Growth Factor ReviewsMitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?
2021, Metabolism: Clinical and Experimental